61.53
price up icon7.85%   4.48
after-market Handel nachbörslich: 62.40 0.87 +1.41%
loading
Schlusskurs vom Vortag:
$57.05
Offen:
$56.91
24-Stunden-Volumen:
694.41K
Relative Volume:
1.14
Marktkapitalisierung:
$1.31B
Einnahmen:
$56.54M
Nettoeinkommen (Verlust:
$-30.70M
KGV:
-157.77
EPS:
-0.39
Netto-Cashflow:
$-31.05M
1W Leistung:
+19.49%
1M Leistung:
+192.72%
6M Leistung:
+179.81%
1J Leistung:
+424.11%
1-Tages-Spanne:
Value
$54.91
$62.16
1-Wochen-Bereich:
Value
$50.25
$62.16
52-Wochen-Spanne:
Value
$10.14
$62.16

Cidara Therapeutics Inc Stock (CDTX) Company Profile

Name
Firmenname
Cidara Therapeutics Inc
Name
Telefon
858-752-6170
Name
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Name
Mitarbeiter
73
Name
Twitter
@CidaraThera
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
CDTX's Discussions on Twitter

Vergleichen Sie CDTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CDTX
Cidara Therapeutics Inc
61.53 1.14B 56.54M -30.70M -31.05M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-18 Fortgesetzt H.C. Wainwright Buy
2025-03-12 Eingeleitet Citizens JMP Mkt Outperform
2025-01-27 Fortgesetzt Cantor Fitzgerald Overweight
2024-12-13 Eingeleitet RBC Capital Mkts Outperform
2024-11-08 Eingeleitet Guggenheim Buy
2024-08-14 Hochstufung H.C. Wainwright Neutral → Buy
2021-12-03 Fortgesetzt H.C. Wainwright Buy
2021-09-22 Hochstufung WBB Securities Buy → Strong Buy
2021-03-04 Eingeleitet Aegis Capital Buy
2019-09-04 Hochstufung Wedbush Neutral → Outperform
2018-07-26 Eingeleitet Citigroup Buy
2017-04-21 Eingeleitet Raymond James Strong Buy
2017-04-17 Bestätigt H.C. Wainwright Buy
2017-04-12 Eingeleitet Ladenburg Thalmann Buy
2017-04-11 Fortgesetzt Wedbush Outperform
2017-02-22 Bestätigt H.C. Wainwright Buy
2017-02-22 Hochstufung WBB Securities Sell → Hold
2016-12-21 Fortgesetzt Leerink Partners Outperform
2016-12-19 Eingeleitet H.C. Wainwright Buy
2016-09-23 Herabstufung WBB Securities Hold → Sell
2015-10-09 Hochstufung WBB Securities Sell → Hold
2015-05-11 Eingeleitet Jefferies Buy
2015-05-11 Eingeleitet Leerink Partners Outperform
2015-05-11 Eingeleitet Needham Buy
2015-05-11 Eingeleitet Wedbush Outperform
2015-04-23 Eingeleitet WBB Securities Sell
Alle ansehen

Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten

pulisher
Jul 22, 2025

Is Cidara Therapeutics Inc. a good long term investmentFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Cidara more than doubles on phase 2 flu preventative data - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Cidara Therapeutics Inc. stockHigh-yield portfolio picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

(CDTX) On The My Stocks Page - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

What drives Cidara Therapeutics Inc. stock priceBreakthrough profit margins - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews

Jul 19, 2025
pulisher
Jul 18, 2025

Cidara Therapeutics Inc. Stock Analysis and ForecastFree Predictions - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Growth or Bubble? Unpacking CDTX Stock Surge - timothysykes.com

Jul 18, 2025
pulisher
Jul 18, 2025

Cidara Therapeutics stock hits 52-week high at 56.85 USD - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Cidara Therapeutics stock hits 52-week high at 56.85 USD By Investing.com - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 16, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Brokerages - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Cidara Therapeutics Inc. stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Cidara Therapeutics Inc. stock attracts strong analyst attentionConsistent Growth Alert - newser.com

Jul 15, 2025
pulisher
Jul 07, 2025

Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com

Jul 07, 2025
pulisher
Jul 07, 2025

Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire

Jul 07, 2025
pulisher
Jul 06, 2025

Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN

Jul 06, 2025
pulisher
Jul 02, 2025

Cidara Therapeutics shares rise 1.47% premarket after granting inducement awards to new employees. - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Jul 01, 2025
pulisher
Jun 30, 2025

Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

hVIVO reports positive results from Cidara’s Phase 2b influenza study By Investing.com - Investing.com Canada

Jun 30, 2025
pulisher
Jun 29, 2025

(CDTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 27, 2025

Phathom Pharmaceuticals shares rise 1.47% premarket after Cidara Therapeutics closes $402.5 million stock offering. - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN

Jun 26, 2025
pulisher
Jun 25, 2025

Cidara Therapeutics Prices $350 Million Public Offering - MarketScreener

Jun 25, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics (CDTX) Price Target Raised by RBC Capital | CDTX Stock News - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics announces $250M public stock offering - MSN

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara stock surges as H.C. Wainwright raises price target on trial data By Investing.com - Investing.com South Africa

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara stock price target raised to $68 on strong flu prevention data - Investing.com Canada

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Form 424B5 Cidara Therapeutics, - StreetInsider

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics (CDTX) to Launch $250M Public Offering | CDT - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics plans $250 million common stock offering By Investing.com - Investing.com Canada

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics (CDTX) Price Target Boosted Following Positi - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics Stock Rises as Strategic Partnerships Strengthen Position - timothysykes.com

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics Announces Positive Topline Results From Its Phase 2B Navigate Trial - TradingView

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics stock rockets after positive flu prevention trial results By Investing.com - Investing.com UK

Jun 23, 2025
pulisher
Jun 20, 2025

Cidara Therapeutics Approves Key Amendments at Annual Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 19, 2025

(CDTX) Proactive Strategies - news.stocktradersdaily.com

Jun 19, 2025
pulisher
Jun 18, 2025

Cidara Therapeutics (CDTX) Receives Buy Rating from HC Wainwrigh - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

H.C. Wainwright assumes coverage on Cidara stock with buy rating By Investing.com - Investing.com UK

Jun 18, 2025
pulisher
Jun 18, 2025

H.C. Wainwright Initiates Coverage on Cidara Therapeutics (CDTX) with Strong Outlook | CDTX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given Overweight Rating at Cantor Fitzgerald - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Cidara Therapeutics (CDTX) Reiterates Overweight Rating by Canto - GuruFocus

Jun 10, 2025
pulisher
Jun 06, 2025

(CDTX) Investment Analysis - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Raises Stock Holdings in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Citizens JMP Reaffirms Their Buy Rating on Cidara Therapeutics (CDTX) - The Globe and Mail

Jun 06, 2025
pulisher
Jun 05, 2025

Cidara Therapeutics stock maintains strong rating at Citizens JMP By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $36.00 at Needham & Company LLC - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Insider Buying: Chrysa Mineo Acquires Shares of Cidara Therapeutics Inc (CDTX) - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Needham raises Cidara Therapeutics stock price target to $36 - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Cidara Therapeutics (CDTX) Price Target Raised by Needham | CDTX Stock News - GuruFocus

Jun 04, 2025

Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):